Large Study of Peripheral Artery Disease Clarifies Treatment Options
Ticagrelor proved no better than clopidogrel for patients with peripheral artery disease DURHAM, N.C. November 13, 2016 – The finding that the drug ticagrelor proved no better than clopidogrel in reducing cardiovascular events for patients with peripheral artery disease should both assure patients about current treatments and demonstrate that new options are still needed, Duke Clinical […]